Recommended Intravenous Dose of Calcium Gluconate for Acute Hypocalcemia in Adults
For acute symptomatic hypocalcemia in adults, administer 1-2 grams (1000-2000 mg) of calcium gluconate (equivalent to 90-180 mg elemental calcium) as an initial IV bolus over 10-20 minutes, followed by a continuous infusion of 10 grams calcium gluconate in 1 liter of D5W or normal saline at 50-100 mL/hour. 1, 2
Initial Bolus Dosing
The most recent and authoritative guidelines establish clear dosing parameters:
- Initial bolus: 1-2 grams of 10% calcium gluconate (10-20 mL) administered IV over 10-20 minutes 1, 2
- This provides 90-180 mg of elemental calcium (each gram of calcium gluconate contains 90 mg elemental calcium) 1, 2
- Must be given with cardiac monitoring due to risk of arrhythmias, particularly bradycardia 1, 2
- Administer through a secure, large-bore IV line 1
Critical threshold for intervention: Treatment is indicated when albumin-corrected serum calcium falls below 7.5 mg/dL (1.9 mmol/L) or when severe symptoms are present (seizures, laryngospasm, tetany, prolonged QTc) regardless of calcium level 1, 3
Continuous Infusion Protocol
Following the initial bolus, transition to maintenance infusion:
- Standard infusion: Mix 10 grams (10 ampules) of calcium gluconate in 1 liter of 5% dextrose or normal saline 1, 3
- Infusion rate: Start at 50-100 mL/hour (equivalent to 0.5-1.0 grams/hour) 1
- Alternative dosing: 0.5-1.5 mg/kg/hour elemental calcium 3
- Target: Restore calcium to just below normal range (low-normal) 1, 3
Monitoring Requirements
Serum calcium monitoring is essential to prevent overcorrection:
- During intermittent infusions: Check ionized or albumin-corrected calcium every 4-6 hours 2
- During continuous infusion: Check every 1-4 hours 2
- Monitor ECG continuously during bolus administration 1, 2
- Check for symptomatic bradycardia and stop infusion if it occurs 4
Important Clinical Considerations
Route and Administration Safety
Central venous access is strongly preferred over peripheral IV 4, 3. The FDA label explicitly warns that extravasation through peripheral lines can cause severe skin and soft tissue injury, including tissue necrosis, ulceration, and calcinosis cutis 2. If only peripheral access is available, ensure the line is secure and durable with a large-bore needle 1.
Calcium Gluconate vs. Calcium Chloride
While calcium chloride provides more elemental calcium per gram (272 mg vs. 90 mg), calcium gluconate is preferred for adult hypocalcemia treatment due to significantly lower risk of tissue necrosis with extravasation 1, 2, 5. Calcium chloride should be reserved for central line administration only 4, 5.
The dose equivalence is approximately 3:1 (calcium gluconate to calcium chloride) 6, 7. If using calcium chloride, 4.4 mL of 7.35% solution equals 10 mL of 10% calcium gluconate 6.
Concurrent Therapy
- Start oral calcium and calcitriol concurrently (calcitriol 0.25-0.5 μg twice daily) 1
- Correct hypomagnesemia first if present, as hypocalcemia cannot be effectively treated without adequate magnesium 1
- Do not mix calcium with bicarbonate or phosphate-containing solutions—precipitation will occur 4, 2
Drug Interactions and Contraindications
Exercise extreme caution with cardiac glycosides (digoxin)—calcium can precipitate life-threatening arrhythmias 2. If concurrent therapy is necessary, give calcium very slowly in small amounts with continuous ECG monitoring 2.
Contraindicated in hypercalcemia and in neonates receiving ceftriaxone (risk of fatal calcium-ceftriaxone precipitates) 2.
Rapid Administration Risks
Never administer calcium gluconate rapidly—this can cause cardiac arrest 1, 3. The infusion rate should not exceed the recommended 10-20 minute timeframe for bolus dosing. Rapid infusion increases risk of hypotension, bradycardia, and cardiac arrhythmias 2.
Special Populations
Geriatric patients: Start at the lower end of the dosing range and monitor closely 2
Renal impairment: Initiate at the lower limit of dosing range with serum calcium monitoring every 4 hours 2
Common Pitfalls to Avoid
- Failing to use cardiac monitoring during bolus administration
- Administering through unsecured peripheral IV without recognizing extravasation risk
- Mixing calcium with bicarbonate or phosphate in the same line
- Overcorrecting calcium above normal range (increases risk of nephrocalcinosis and soft tissue calcification)
- Not correcting concurrent hypomagnesemia, which prevents effective calcium repletion
- Rapid infusion without appropriate dilution and timing
The evidence consistently supports this graduated approach: initial bolus for acute symptom control followed by continuous infusion titrated to maintain low-normal calcium levels while addressing the underlying cause 1, 3, 2.